tiprankstipranks
Aspen Aerogels Inc (ASPN)
NYSE:ASPN
Want to see ASPN full AI Analyst Report?

Aspen Aerogels (ASPN) AI Stock Analysis

1,247 Followers

Top Page

ASPN

Aspen Aerogels

(NYSE:ASPN)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
$6.50
▲(86.78% Upside)
Action:Reiterated
Date:05/19/26
ASPN scores slightly below average primarily due to weak and volatile profitability (TTM losses and low margins) despite improved TTM cash generation and manageable leverage. Technicals are supportive with strong price momentum, but overbought readings add near-term risk. The latest earnings call adds some support via sequential-growth guidance and strong liquidity, though operational disruption and continued negative EBITDA temper the outlook.
Positive Factors
Strong liquidity and cash generation
A liquid balance sheet with $175.6M in cash, positive Q1 cash generation and covenant headroom provides a durable cushion to fund restart costs, scheduled debt payments, low ongoing CapEx (<$10M), and investments to scale operations. This reduces near‑term refinancing risk and supports multi‑quarter execution on growth targets without relying on short-term capital markets.
Negative Factors
Weak and volatile profitability
Trailing profitability is inconsistent: a brief profitable 2024 gave way to a return to sizable losses and very weak TTM gross margins. Persistent low gross margins and negative net margins impair the firm’s ability to self‑fund growth and mean sustained margin improvement is required to reach structural EBITDA breakeven and justify long‑term capital allocation.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong liquidity and cash generation
A liquid balance sheet with $175.6M in cash, positive Q1 cash generation and covenant headroom provides a durable cushion to fund restart costs, scheduled debt payments, low ongoing CapEx (<$10M), and investments to scale operations. This reduces near‑term refinancing risk and supports multi‑quarter execution on growth targets without relying on short-term capital markets.
Read all positive factors

Aspen Aerogels Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Highlights revenue contributions from different business areas, providing insight into which segments drive growth and profitability, and how the company balances its portfolio.
Chart InsightsRevenue is now heavily concentrated in Thermal Barrier after Subsea and Research Services faded, leaving ASPN exposed to EV OEM cycles that drove sharp peaks and recent pullbacks; Energy Industrial shows volatility but management expects it to rebound (and to be a 2026 growth driver alongside European OEM wins and a new BESS initiative). Structural cost cuts and strong cash provide a buffer and improve breakeven, but near‑term downside remains—Q1 is guided as the seasonal low with negative adjusted EBITDA—so the story hinges on converting the European pipeline and sustaining volume recovery.
Data provided by:The Fly

Aspen Aerogels (ASPN) vs. SPDR S&P 500 ETF (SPY)

Aspen Aerogels Business Overview & Revenue Model

Company Description
Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company of...
How the Company Makes Money
Aspen Aerogels makes money primarily by selling aerogel-based thermal insulation products to customers, generating revenue from product shipments under customer purchase orders and supply agreements. A key revenue stream is industrial insulation, ...

Aspen Aerogels Earnings Call Summary

Earnings Call Date:May 07, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Jul 23, 2026
Earnings Call Sentiment Neutral
The call balanced material near-term operational challenges (an April plant explosion, related elevated costs, supply-chain and regional disruptions, and negative adjusted EBITDA guidance for Q2) with meaningful positives: a strong cash position bolstered by a $37.6M GM claim, improved quarter-over-quarter profitability metrics (GAAP loss and adjusted EBITDA), robust demand signals and multi-faceted growth drivers in Energy & Industrial (subsea, LNG, maintenance), significant momentum in European thermal barriers (>3x YoY), and explicit guidance for sequential revenue growth with targets (20% EI growth in 2026, Q2 revenue range $40M–$48M). Given the mix of short-term operational headwinds and credible near- to medium-term growth and liquidity strengths, the overall tone is cautious but constructive.
Positive Updates
Q1 Revenue and Segment Mix
Total Q1 2026 revenue of $37.9M, comprised of $21.6M Energy & Industrial and $16.3M Thermal Barrier. Company reiterates expectation of sequential revenue growth each quarter through 2026.
Negative Updates
East Providence Plant Explosion and Operational Disruption
April 8 explosion in a high-temperature oven caused localized plant damage and temporary cessation of operations at East Providence. Staged restart expected to begin in May subject to safety and regulatory reviews; full capability restoration will take time.
Read all updates
Q1-2026 Updates
Negative
Q1 Revenue and Segment Mix
Total Q1 2026 revenue of $37.9M, comprised of $21.6M Energy & Industrial and $16.3M Thermal Barrier. Company reiterates expectation of sequential revenue growth each quarter through 2026.
Read all positive updates
Company Guidance
The company guided to sequential revenue growth through 2026, with Q2 revenue expected between $40.0M and $48.0M (up roughly 5%–28% quarter‑over‑quarter from Q1’s $37.9M, which included $21.6M Energy & Industrial and $16.3M thermal barrier), and Q2 adjusted EBITDA of negative $10M to negative $4M (Q1 adjusted EBITDA was negative $12.7M and GAAP net loss was $23.7M). Management reiterated a target of ~20% Energy & Industrial growth in 2026 and the ambition to scale that segment into a $200M high‑margin business, with EU thermal barrier revenue expected to be ~$10M–$15M in 2026; they also expect EBITDA breakeven at roughly $50M of quarterly revenue and have reduced breakeven from $330M (2024) to $200M (2026) and to $175M by end of 2027. Liquidity guidance included Q1 cash of $175.6M (up from $158.6M), $37.6M GM claim proceeds recognized ratably through 2027 ( $3.5M booked in Q1, ~$4.9M/quarter thereafter), an $86M term‑loan balance with covenant headroom (cash ≥ 100% of term loan), full‑year CapEx < $10M, scheduled debt payments of ~ $26M, and the expectation that Q2 cash outflows could be $20M–$30M (including ~ $12M of CapEx and scheduled debt payments) while they manage elevated near‑term costs from the East Providence disruption.

Aspen Aerogels Financial Statement Overview

Summary
Financials are mixed and skewed negative: TTM revenue is down (~15%) and profitability is weak (TTM gross margin ~12% and net margin ~-49%) after a brief profitable 2024. Offsetting this, leverage appears manageable (TTM debt-to-equity ~0.32) and cash flow improved in TTM with positive operating cash flow (~$61M) and free cash flow (~$36M), though cash generation has been inconsistent across prior years.
Income Statement
38
Negative
Balance Sheet
63
Positive
Cash Flow
55
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue230.26M271.10M452.70M238.72M180.36M121.62M
Gross Profit27.46M46.00M182.90M56.92M4.98M9.94M
EBITDA-52.82M5.72B51.46M-22.31M-68.41M-27.43M
Net Income-111.99M-389.55M13.38M-45.81M-82.74M-37.09M
Balance Sheet
Total Assets410.48M406.68M895.14M703.05M643.42M182.95M
Cash, Cash Equivalents and Short-Term Investments175.58M156.86M220.88M139.72M281.33M76.56M
Total Debt128.82M143.71M197.38M138.77M119.40M15.24M
Total Liabilities196.98M171.16M280.44M214.99M195.98M54.55M
Stockholders Equity213.50M235.52M614.71M488.06M447.44M128.41M
Cash Flow
Free Cash Flow35.57M-4.58M-40.71M-218.07M-272.37M-32.41M
Operating Cash Flow61.38M32.87M45.55M-42.61M-94.40M-18.63M
Investing Cash Flow-25.82M-37.45M-86.26M-175.46M-177.97M-13.78M
Financing Cash Flow-52.42M-58.13M122.02M75.48M478.37M92.47M

Aspen Aerogels Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.48
Price Trends
50DMA
4.19
Positive
100DMA
3.79
Positive
200DMA
4.74
Positive
Market Momentum
MACD
0.62
Negative
RSI
74.55
Negative
STOCH
86.96
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASPN, the sentiment is Positive. The current price of 3.48 is below the 20-day moving average (MA) of 5.27, below the 50-day MA of 4.19, and below the 200-day MA of 4.74, indicating a bullish trend. The MACD of 0.62 indicates Negative momentum. The RSI at 74.55 is Negative, neither overbought nor oversold. The STOCH value of 86.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ASPN.

Aspen Aerogels Risk Analysis

Aspen Aerogels disclosed 60 risk factors in its most recent earnings report. Aspen Aerogels reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Aspen Aerogels Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$249.30M14.6020.37%33.17%87.28%
70
Neutral
$820.09M14.9910.79%2.77%3.21%-34.89%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
52
Neutral
$530.42M-4.73-42.12%-47.30%61.05%
52
Neutral
$854.83M-3.52-30.23%2.12%28.35%-939.66%
47
Neutral
$404.61M-101.41-0.65%1.38%-111.51%
46
Neutral
$1.15B128.430.94%-4.66%-201.96%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASPN
Aspen Aerogels
6.40
0.71
12.48%
APOG
Apogee
38.41
1.51
4.10%
BXC
Bluelinx Holdings
51.99
-12.75
-19.69%
ROCK
Gibraltar Industries
38.65
-18.57
-32.45%
PPIH
Perma-Pipe International Holdings
30.69
17.16
126.83%
NX
Quanex
18.61
2.62
16.36%

Aspen Aerogels Corporate Events

Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Aspen Aerogels Resumes Plant Operations After Safety Incident
Positive
May 18, 2026
On May 13, 2026, Aspen Aerogels&#8217; board named Chief Financial Officer Grant Thoele as principal accounting officer, consolidating its top finance and accounting roles and raising his base salary to $425,000 effective April 1, 2026, while keep...
Business Operations and StrategyFinancial Disclosures
Aspen Aerogels Details Q1 Results and Plant Explosion
Negative
May 7, 2026
Aspen Aerogels reported that first-quarter 2026 revenue fell to $37.9 million from $78.7 million a year earlier, as thermal barrier sales dropped sharply due to changes in regulatory frameworks and incentive programs, while energy industrial reven...
Business Operations and StrategyFinancial Disclosures
Aspen Aerogels Shuts Rhode Island Plant After Explosion
Negative
Apr 21, 2026
Aspen Aerogels reported that an explosion at its East Providence, Rhode Island manufacturing facility on April 8, 2026 damaged part of the production area and forced a temporary shutdown of operations. The incident, which preliminary findings link...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 19, 2026